Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA).
Grossman RI, Rubin DL, Hunter G, Haughton VM, Lee D, Sze G, Kuhn MJ, Maravilla K, Tu R, Heindel W, Wippold FJ 2nd, Leeds N, Zelch J, Jinkins JR, Grodd W, Truwit C, Kanal E, Provenzale JM, Ramsey R, Simon J, Brunberg JA, Stevens GR, Kristy RM.
Grossman RI, et al. Among authors: simon j.
Invest Radiol. 2000 Jul;35(7):412-9. doi: 10.1097/00004424-200007000-00003.
Invest Radiol. 2000.
PMID: 10901102
Clinical Trial.